NM_002185.5:c.1241C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BS2_Supporting

This summary comes from the ClinGen Evidence Repository: The NM_002185.5(IL7R):c.1241C>T (p.Thr414Met) missense variant occurs at a frequency too high for the disease. The filtering allele frequency based on the South Asian population (upper bound of 95% CI of 1076/30502 observed alleles) is 0.03353 in gnomAD v2.1.1, which is above the SCID-VCEP BA1 threshold (>0.00566). Also, 46 adult homozygous individuals with this variant are present in gnomAD v2.1.1 (BS2_Supporting). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: BA1 and BS2_Supporting (SCID VCEP specifications version 1.0). LINK:https://erepo.genome.network/evrepo/ui/classification/CA160123/MONDO:0012163/119

Frequency

Genomes: 𝑓 0.0059 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0071 ( 144 hom. )

Consequence

IL7R
NM_002185.5 missense

Scores

3
14

Clinical Significance

Benign reviewed by expert panel B:5O:1

Conservation

PhyloP100: -0.111

Publications

22 publications found
Variant links:
Genes affected
IL7R (HGNC:6024): (interleukin 7 receptor) The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]
IL7R Gene-Disease associations (from GenCC):
  • immunodeficiency 104
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • Omenn syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL7RNM_002185.5 linkc.1241C>T p.Thr414Met missense_variant Exon 8 of 8 ENST00000303115.8 NP_002176.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL7RENST00000303115.8 linkc.1241C>T p.Thr414Met missense_variant Exon 8 of 8 1 NM_002185.5 ENSP00000306157.3

Frequencies

GnomAD3 genomes
AF:
0.00585
AC:
890
AN:
152150
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.0300
Gnomad SAS
AF:
0.0323
Gnomad FIN
AF:
0.00679
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00475
Gnomad OTH
AF:
0.0101
GnomAD2 exomes
AF:
0.0103
AC:
2573
AN:
250690
AF XY:
0.0117
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00194
Gnomad ASJ exome
AF:
0.0149
Gnomad EAS exome
AF:
0.0267
Gnomad FIN exome
AF:
0.00766
Gnomad NFE exome
AF:
0.00475
Gnomad OTH exome
AF:
0.0127
GnomAD4 exome
AF:
0.00711
AC:
10387
AN:
1460904
Hom.:
144
Cov.:
33
AF XY:
0.00816
AC XY:
5930
AN XY:
726624
show subpopulations
African (AFR)
AF:
0.00167
AC:
56
AN:
33434
American (AMR)
AF:
0.00226
AC:
101
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
351
AN:
26066
East Asian (EAS)
AF:
0.0358
AC:
1422
AN:
39682
South Asian (SAS)
AF:
0.0372
AC:
3209
AN:
86186
European-Finnish (FIN)
AF:
0.00847
AC:
452
AN:
53370
Middle Eastern (MID)
AF:
0.0239
AC:
138
AN:
5764
European-Non Finnish (NFE)
AF:
0.00371
AC:
4127
AN:
1111360
Other (OTH)
AF:
0.00880
AC:
531
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
603
1206
1809
2412
3015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00586
AC:
893
AN:
152268
Hom.:
9
Cov.:
32
AF XY:
0.00661
AC XY:
492
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41546
American (AMR)
AF:
0.00431
AC:
66
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3468
East Asian (EAS)
AF:
0.0301
AC:
156
AN:
5184
South Asian (SAS)
AF:
0.0326
AC:
157
AN:
4820
European-Finnish (FIN)
AF:
0.00679
AC:
72
AN:
10606
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00475
AC:
323
AN:
68026
Other (OTH)
AF:
0.00997
AC:
21
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
47
94
140
187
234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00579
Hom.:
24
Bravo
AF:
0.00516
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00547
AC:
47
ExAC
AF:
0.0107
AC:
1302
Asia WGS
AF:
0.0200
AC:
71
AN:
3478
EpiCase
AF:
0.00660
EpiControl
AF:
0.00539

ClinVar

Significance: Benign
Submissions summary: Benign:5Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Immunodeficiency 104 Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 10, 2023
ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The NM_002185.5(IL7R):c.1241C>T (p.Thr414Met) missense variant occurs at a frequency too high for the disease. The filtering allele frequency based on the South Asian population (upper bound of 95% CI of 1076/30502 observed alleles) is 0.03353 in gnomAD v2.1.1, which is above the SCID-VCEP BA1 threshold (>0.00566). Also, 46 adult homozygous individuals with this variant are present in gnomAD v2.1.1 (BS2_Supporting). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: BA1 and BS2_Supporting (SCID VCEP specifications version 1.0).

not specified Benign:1Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Mar 22, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
7.2
DANN
Uncertain
0.99
DEOGEN2
Benign
0.36
T
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.046
N
LIST_S2
Benign
0.69
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PhyloP100
-0.11
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.11
Sift
Uncertain
0.015
D
Sift4G
Uncertain
0.031
D
Vest4
0.047
ClinPred
0.020
T
GERP RS
-1.1
Varity_R
0.020
gMVP
0.40
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229232; hg19: chr5-35876449; COSMIC: COSV57406871; COSMIC: COSV57406871; API